Coronary and pulmonary vascular effects of leukotrienes and PAF-acether

R. E. Goldstein; D. Ezra; F. R.M. Laurindo; G. Z. Feuerstein

doi:10.1016/0031-6989(86)90048-2

Coronary and pulmonary vascular effects of leukotrienes and PAF-acether

R. E. Goldstein^*, D. Ezra, F. R.M. Laurindo, G. Z. Feuerstein

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Original language	English
Pages (from-to)	151-162
Number of pages	12
Journal	Pharmacological Research Communications
Volume	18
Issue number	SUPPL.
DOIs	https://doi.org/10.1016/0031-6989(86)90048-2
State	Published - Aug 1986
Externally published	Yes

Access to Document

10.1016/0031-6989(86)90048-2

Cite this

@article{7981a77a63fa4efbbfe9ee37888566be,

title = "Coronary and pulmonary vascular effects of leukotrienes and PAF-acether",

author = "Goldstein, {R. E.} and D. Ezra and Laurindo, {F. R.M.} and Feuerstein, {G. Z.}",

note = "Funding Information: In summary, sufficiently large infusion of either LT or PAF-acether can cause lethal systemic hypotension and underperfusion. For LT, this is likely to reflect severe left ventricular dysfunction; for PAF-acether. this outcome primarily reflects right ventricular dysfunction. ACKNOWLEDGEMENT Research Sciences, in Clinical International of Health. Mr. John was supported by the Uniformed Services University of the Health Protocols R08346 and G19214. Dr. Ezra was an International Fellow Pharmacology of the Merck Foundation and Dr. Laurindo is an Research Fellow of the Fogarty Foundation, National Institutes The authors are grateful for the technical assistance of Czaja.",

year = "1986",

month = aug,

doi = "10.1016/0031-6989(86)90048-2",

language = "English",

volume = "18",

pages = "151--162",

journal = "Pharmacological Research Communications",

issn = "0031-6989",

number = "SUPPL.",

}

TY - JOUR

T1 - Coronary and pulmonary vascular effects of leukotrienes and PAF-acether

AU - Goldstein, R. E.

AU - Ezra, D.

AU - Laurindo, F. R.M.

AU - Feuerstein, G. Z.

N1 - Funding Information: In summary, sufficiently large infusion of either LT or PAF-acether can cause lethal systemic hypotension and underperfusion. For LT, this is likely to reflect severe left ventricular dysfunction; for PAF-acether. this outcome primarily reflects right ventricular dysfunction. ACKNOWLEDGEMENT Research Sciences, in Clinical International of Health. Mr. John was supported by the Uniformed Services University of the Health Protocols R08346 and G19214. Dr. Ezra was an International Fellow Pharmacology of the Merck Foundation and Dr. Laurindo is an Research Fellow of the Fogarty Foundation, National Institutes The authors are grateful for the technical assistance of Czaja.

PY - 1986/8

Y1 - 1986/8

UR - http://www.scopus.com/inward/record.url?scp=0022496714&partnerID=8YFLogxK

U2 - 10.1016/0031-6989(86)90048-2

DO - 10.1016/0031-6989(86)90048-2

M3 - Article

C2 - 3774842

AN - SCOPUS:0022496714

SN - 0031-6989

VL - 18

SP - 151

EP - 162

JO - Pharmacological Research Communications

JF - Pharmacological Research Communications

IS - SUPPL.

ER -

Coronary and pulmonary vascular effects of leukotrienes and PAF-acether

Access to Document

Fingerprint

Cite this